scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0306-4522(00)00241-4 |
P698 | PubMed publication ID | 10974429 |
P2093 | author name string | R Mason | |
D A Kendall | |||
C A Marsden | |||
J F Cheer | |||
P2860 | cites work | Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 |
Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons | Q28245016 | ||
Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme | Q28372132 | ||
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
The dopamine hypothesis of reward: past and current status | Q33756130 | ||
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
Mesolimbic dopaminergic decline after cannabinoid withdrawal | Q34750833 | ||
Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology | Q39643228 | ||
Synaptic regulation of mesocorticolimbic dopamine neurons | Q41132697 | ||
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor | Q42445979 | ||
Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
Δ9-Tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent mannier in rat brain | Q44491492 | ||
Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. | Q46383884 | ||
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice | Q47628019 | ||
Cannabinoid transmission and reward-related events | Q48285165 | ||
Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats | Q48422397 | ||
Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist | Q48484213 | ||
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors | Q48518726 | ||
Opioids excite dopamine neurons by hyperpolarization of local interneurons | Q48543154 | ||
The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. | Q50933545 | ||
Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. | Q52529851 | ||
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity | Q64386018 | ||
A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing | Q67270148 | ||
The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study | Q69853528 | ||
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes | Q71407604 | ||
Neurotransmitter regulation of dopamine neurons in the ventral tegmental area | Q72215317 | ||
L-glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: extra- and intracellular electrophysiological studies in brain slices | Q72666284 | ||
Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment | Q73500317 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | electrophysiology | Q1154774 |
cannabinoids | Q422936 | ||
P304 | page(s) | 661-667 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study | |
P478 | volume | 99 |
Q38036236 | A brain on cannabinoids: the role of dopamine release in reward seeking |
Q34676610 | Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? |
Q37760048 | Cannabinoid conditioned reward and aversion: behavioral and neural processes. |
Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
Q44298237 | Cannabinoid-induced Fos expression within A10 dopaminergic neurons |
Q36393644 | Cannabinoids and value-based decision making: implications for neurodegenerative disorders. |
Q44885114 | Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. |
Q44666878 | Cannabinoids modulate ultrasound-induced aversive responses in rats |
Q30807024 | Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data |
Q62725703 | Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis |
Q44385248 | Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum |
Q44830723 | Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain |
Q28297001 | Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse |
Q36201313 | Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats |
Q44563666 | Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats |
Q47319226 | Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens |
Q39400299 | Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling |
Q38250054 | Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues |
Q36452302 | Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
Q33645739 | Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. |
Q44051647 | Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids |
Q44048463 | Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. |
Q24671514 | Marijuana and cannabinoid regulation of brain reward circuits |
Q34430714 | Modulation of transmitter release via presynaptic cannabinoid receptors |
Q48273958 | Neurosystems linking corticolimbic and hypothalamic pathways in energy balance: view from the Chair |
Q96953338 | One Is Not Enough: Understanding and Modeling Polysubstance Use |
Q35779281 | Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal |
Q37226537 | Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). |
Q46504765 | Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons. |
Q38126265 | Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? |
Q64229781 | The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder |
Q42485353 | The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice |
Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
Q26770739 | To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making |
Q38044684 | Using dopamine research to generate rational cannabinoid drug policy |
Search more.